{
  "configurations": [
    {
      "nodes": [
        {
          "cpeMatch": [
            {
              "criteria": "cpe:2.3:a:sas:sas_drug_development:*:*:*:*:*:*:*:*",
              "matchCriteriaId": "FCB9AF1A-F40F-441A-9B94-4955D92C9655",
              "versionEndExcluding": "32drg02",
              "vulnerable": true
            }
          ],
          "negate": false,
          "operator": "OR"
        }
      ]
    }
  ],
  "cveTags": [],
  "descriptions": [
    {
      "lang": "en",
      "value": "SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser."
    },
    {
      "lang": "es",
      "value": "SAS Drug Development (SDD) anterior de 32DRG02 maneja mal las acciones de cierre de sesión, lo que permite a un usuario (que había iniciado sesión previamente) acceder a los recursos presionando un botón de retroceso o avance en un navegador web"
    }
  ],
  "id": "CVE-2007-6763",
  "lastModified": "2019-08-12T02:35:11.033",
  "metrics": {
    "cvssMetricV2": [
      {
        "acInsufInfo": false,
        "baseSeverity": "MEDIUM",
        "cvssData": {
          "accessComplexity": "LOW",
          "accessVector": "NETWORK",
          "authentication": "SINGLE",
          "availabilityImpact": "PARTIAL",
          "baseScore": 6.5,
          "confidentialityImpact": "PARTIAL",
          "integrityImpact": "PARTIAL",
          "vectorString": "AV:N/AC:L/Au:S/C:P/I:P/A:P",
          "version": "2.0"
        },
        "exploitabilityScore": 8.0,
        "impactScore": 6.4,
        "obtainAllPrivilege": false,
        "obtainOtherPrivilege": false,
        "obtainUserPrivilege": false,
        "source": "nvd@nist.gov",
        "type": "Primary",
        "userInteractionRequired": false
      }
    ],
    "cvssMetricV30": [
      {
        "cvssData": {
          "attackComplexity": "LOW",
          "attackVector": "NETWORK",
          "availabilityImpact": "HIGH",
          "baseScore": 8.8,
          "baseSeverity": "HIGH",
          "confidentialityImpact": "HIGH",
          "integrityImpact": "HIGH",
          "privilegesRequired": "LOW",
          "scope": "UNCHANGED",
          "userInteraction": "NONE",
          "vectorString": "CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H",
          "version": "3.0"
        },
        "exploitabilityScore": 2.8,
        "impactScore": 5.9,
        "source": "nvd@nist.gov",
        "type": "Primary"
      }
    ]
  },
  "published": "2019-07-31T18:15:10.753",
  "references": [
    {
      "source": "cve@mitre.org",
      "tags": [
        "Vendor Advisory"
      ],
      "url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf"
    }
  ],
  "sourceIdentifier": "cve@mitre.org",
  "vulnStatus": "Analyzed",
  "weaknesses": [
    {
      "description": [
        {
          "lang": "en",
          "value": "CWE-20"
        }
      ],
      "source": "nvd@nist.gov",
      "type": "Primary"
    }
  ]
}